Your browser is no longer supported. Please, upgrade your browser.
Settings
TTOO T2 Biosystems, Inc. daily Stock Chart
TTOO [NASD]
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-1.35 Insider Own1.60% Shs Outstand47.46M Perf Week2.63%
Market Cap55.53M Forward P/E- EPS next Y-0.89 Insider Trans-1.24% Shs Float39.53M Perf Month8.33%
Income-60.10M PEG- EPS next Q-0.26 Inst Own23.80% Short Float8.95% Perf Quarter-51.05%
Sales7.10M P/S7.82 EPS this Y35.10% Inst Trans-0.22% Short Ratio5.55 Perf Half Y-20.41%
Book/sh-0.57 P/B- EPS next Y29.90% ROA-120.70% Target Price6.41 Perf Year-66.57%
Cash/sh0.34 P/C3.43 EPS next 5Y- ROE757.90% 52W Range0.52 - 5.38 Perf YTD0.00%
Dividend- P/FCF- EPS past 5Y3.80% ROI-83.80% 52W High-78.25% Beta1.08
Dividend %- Quick Ratio0.30 Sales past 5Y108.60% Gross Margin- 52W Low125.00% ATR0.09
Employees153 Current Ratio0.40 Sales Q/Q-32.00% Oper. Margin- RSI (14)45.68 Volatility6.73% 8.27%
OptionableYes Debt/Eq- EPS Q/Q-26.80% Profit Margin- Rel Volume0.92 Prev Close1.17
ShortableYes LT Debt/Eq- EarningsNov 12 BMO Payout- Avg Volume636.94K Price1.17
Recom2.10 SMA200.91% SMA50-10.33% SMA200-37.16% Volume582,114 Change0.00%
Nov-26-19Downgrade Janney Buy → Neutral
Aug-01-19Downgrade Alliance Global Partners Buy → Neutral
Jul-31-19Downgrade Janney Buy → Neutral
Jul-31-19Downgrade H.C. Wainwright Buy → Neutral
May-16-19Initiated Alliance Global Partners Buy $5
Mar-08-19Reiterated H.C. Wainwright Buy $14 → $11
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
May-29-18Reiterated WBB Securities Strong Buy $12 → $20
Mar-29-18Reiterated H.C. Wainwright Buy $8 → $8.50
Jan-29-18Initiated Goldman Neutral $5.20
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Feb-17-16Initiated WBB Securities Speculative Buy $11
Feb-10-16Initiated Cantor Fitzgerald Buy $15
Jan-17-20 04:15PM  T2 Biosystems Reports Granting of Inducement Award GlobeNewswire
Jan-13-20 07:30AM  T2 Biosystems Promotes Tony Pare to Chief Commercial Officer GlobeNewswire
Jan-10-20 07:13AM  The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx Benzinga
Jan-09-20 04:30PM  T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results GlobeNewswire
04:15PM  T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer GlobeNewswire
Dec-23-19 08:05PM  Is T2 Biosystems Inc (TTOO) Going To Burn These Hedge Funds ? Insider Monkey +9.09%
Dec-13-19 04:15PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-29-19 08:52AM  Edited Transcript of TTOO earnings conference call or presentation 12-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-20-19 07:30AM  T2 Biosystems Announces Granting of CE-Mark for T2Resistance Panel GlobeNewswire
Nov-15-19 07:30AM  T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire +16.56%
Nov-12-19 07:30AM  T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update GlobeNewswire -27.78%
Nov-08-19 04:15PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-07-19 07:30AM  T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019) GlobeNewswire
06:08AM  These 36 Mass. firms made Deloitte's Technology Fast 500 American City Business Journals
Nov-05-19 10:33AM  Analysts Estimate T2 Biosystems (TTOO) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-31-19 04:15PM  T2 Biosystems Announces 2019 Third Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
10:34AM  Earnings Preview: T2 Biosystems (TTOO) Q3 Earnings Expected to Decline Zacks
Oct-11-19 07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +5.35%
Oct-09-19 02:13PM  Introducing T2 Biosystems (NASDAQ:TTOO), The Stock That Tanked 84% Simply Wall St.
Oct-02-19 07:30AM  T2 Biosystems to Showcase Latest Innovations at IDWeek 2019 GlobeNewswire
Sep-30-19 07:30AM  T2 Biosystems T2Resistance Panel is Now Available as a Research Use Only (RUO) Test in the U.S. GlobeNewswire
Sep-26-19 04:15PM  T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-25-19 07:30AM  T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands GlobeNewswire
Sep-24-19 07:00AM  T2 Biosystems T2Resistance Panel is First Diagnostic to Graduate from CARB-X Portfolio GlobeNewswire
Sep-19-19 07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +12.11%
Sep-13-19 04:39AM  2 Downtrodden Small Biotechs That Are Showing Signs of Life TheStreet.com
Sep-11-19 03:11PM  Shares of T2 Biosystems rise on federal contract for diagnostic tests American City Business Journals +82.52%
09:30AM  T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections GlobeNewswire
Sep-10-19 04:21PM  T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract GlobeNewswire
04:14PM  T2 Biosystems Announces Restructuring of CRG Term Loan Agreement GlobeNewswire
04:05PM  T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc. GlobeNewswire
Aug-30-19 11:32AM  How Much is T2 Biosystems, Inc.'s (NASDAQ:TTOO) CEO Getting Paid? Simply Wall St. -11.33%
Aug-29-19 07:30AM  T2 Biosystems to Present at the Janney Healthcare Conference 2019 GlobeNewswire +7.14%
Aug-28-19 09:03AM  Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock? Zacks
Aug-26-19 07:42AM  4 Defensible Healthcare Stocks Gaining While the Market Falls TipRanks +11.76%
Aug-16-19 07:30AM  T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand GlobeNewswire
Aug-14-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire -7.72%
Aug-06-19 07:30AM  T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS GlobeNewswire +20.41%
Aug-03-19 02:08PM  Edited Transcript of TTOO earnings conference call or presentation 30-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-02-19 04:53AM  Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts TheStreet.com +5.45%
Jul-31-19 10:31AM  Lexington diagnostics maker T2 Biosystems' stock plummets on CEO departure, low earnings American City Business Journals -59.03%
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
Jul-30-19 06:45PM  T2 Biosystems (TTOO) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:01PM  T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
07:30AM  T2 Biosystems to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-26-19 07:30AM  T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies GlobeNewswire
Jul-24-19 07:30AM  T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-16-19 10:03AM  Before You Buy T2 Biosystems, Inc. (NASDAQ:TTOO), Consider Its Volatility Simply Wall St. +10.32%
Jul-03-19 07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-28-19 07:30AM  T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts GlobeNewswire +7.01%
Jun-20-19 07:30AM  T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019 GlobeNewswire
Jun-17-19 07:30AM  T2 Biosystems Highlights Current and Future Opportunities for its Breakthrough Rapid Diagnostic Technology for Biothreat Pathogen Detection GlobeNewswire
Jun-12-19 07:30AM  T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings GlobeNewswire +8.92%
Jun-10-19 01:06PM  Do Institutions Own T2 Biosystems, Inc. (NASDAQ:TTOO) Shares? Simply Wall St.
07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-06-19 07:30AM  New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department GlobeNewswire
May-24-19 07:30AM  T2 Biosystems to Participate in Singular Research Spring Select Web Call GlobeNewswire
May-23-19 11:08AM  Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings GlobeNewswire -19.07%
May-14-19 07:00AM  Publication in Annals of Internal Medicine® Reveals T2Bacteria® Panel as the First Direct-from-Blood, Non-Culture Test that Rapidly Diagnoses Bacterial Bloodstream Infections GlobeNewswire
May-13-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
May-08-19 02:45PM  T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida GlobeNewswire
May-07-19 05:52PM  Edited Transcript of TTOO earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-02-19 06:55PM  T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:47PM  T2 Biosystems: 1Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Apr-29-19 09:41AM  Can Mass Cytometry Drive Fluidigm's (FLDM) Q1 Earnings? Zacks
09:25AM  Integer Holdings (ITGR) Q1 Earnings: What's in the Cards? Zacks
Apr-25-19 10:33AM  T2 Biosystems (TTOO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-18-19 04:30PM  T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
12:14PM  Will T2 Biosystems, Inc.'s (NASDAQ:TTOO) Earnings Grow In The Years Ahead? Simply Wall St.
Apr-08-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +12.73%
Apr-03-19 07:30AM  T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference GlobeNewswire
Mar-27-19 12:18AM  Edited Transcript of TTOO earnings conference call or presentation 7-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-13-19 12:00PM  T2 Biosystems, Inc.s (NASDAQ:TTOO) Shift From Loss To Profit Simply Wall St.
Mar-07-19 04:01PM  T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
08:45AM  Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock? Zacks
Mar-01-19 08:30AM  3 Recent Big Gainers Kick Off the Dramatic Return of 'Small-Cap Friday' TheStreet.com
Feb-28-19 08:24AM  The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems Benzinga +15.43%
Feb-27-19 04:01PM  FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance Panel; Expected Availability through CE Mark in 2019 GlobeNewswire -5.05%
Feb-26-19 07:30AM  Detailed Research: Economic Perspectives on Altice, Just Energy Group, Ultra Petroleum, RadNet, T2 Biosystems, and Calumet Specialty Products Partners What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-21-19 07:30AM  T2 Biosystems to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-20-19 04:30PM  T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date GlobeNewswire
12:00PM  Fast Company Names T2Biosystems One of the Worlds Most Innovative Companies For Battling Sepsis in Hours not Days GlobeNewswire
Feb-07-19 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire -12.66%
Jan-23-19 07:00AM  T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria GlobeNewswire
Jan-18-19 11:50AM  Our Take On T2 Biosystems, Inc.s (NASDAQ:TTOO) CEO Salary Simply Wall St.
Jan-08-19 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Dec-20-18 09:41AM  Is T2 Biosystems Inc (TTOO) Going to Burn These Hedge Funds? Insider Monkey
Dec-07-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-29-18 07:45AM  New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-13-18 11:41AM  How Many T2 Biosystems Inc (NASDAQ:TTOO) Shares Do Institutions Own? Simply Wall St.
Nov-12-18 03:26PM  Edited Transcript of TTOO earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
08:40AM  Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems Zacks
Nov-09-18 06:47AM  Bet on Rising P/E Investing With These 5 Top-Ranked Stocks Zacks
Nov-08-18 07:00AM  T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire
Nov-07-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-01-18 05:30PM  T2 Biosystems: 3Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-22-18 07:20AM  Consolidated Research: 2018 Summary Expectations for Vuzix, BCE, Tetraphase Pharmaceuticals, T2 Biosystems, TPG Specialty Lending, and Jianpu Technology Fundamental Analysis, Key Performance Indications GlobeNewswire +11.39%
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it is developing Candida Auris, a multi-drug resistant pathogen; T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; and T2Lyme for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC to develop detection diagnostic test panel that adds one additional bacteria species to the existing T2Bacteria product candidate, as well as for testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elsbree David BDirectorJan 03Sale1.165,3166,16791,081Jan 07 02:12 PM
Barclay AlecSVP, OperationsSep 11Sale2.924,21012,29342,102Sep 13 06:05 AM
Cima Michael J.DirectorJun 11Sale1.433,2404,633213,178Jun 13 04:31 PM
CUMMING JOHN WDirectorJun 11Sale1.433,4204,89123,580Jun 13 04:30 PM
Lapidus StanleyDirectorJun 11Sale1.449,00012,96053,010Jun 13 04:30 PM
Elsbree David BDirectorJun 11Sale1.443,6005,18483,108Jun 13 04:30 PM
Lowery Thomas J.Chief Scientific OfficerFeb 11Sale3.363,00510,09769,704Feb 12 04:52 PM
Gibbs Michael TerrenceGeneral CounselFeb 11Sale3.363,00510,09757,237Feb 12 04:51 PM
McDonough JohnPresident & CEOFeb 11Sale3.368,13427,330448,220Feb 12 04:47 PM
Gibbs Michael TerrenceGeneral CounselFeb 01Sale3.471,8206,31554,428Feb 05 04:55 PM
McDonough JohnPresident & CEOFeb 01Sale3.479,44332,767439,688Feb 05 04:54 PM
Lowery Thomas J.Chief Scientific OfficerFeb 01Sale3.474,18514,52266,875Feb 05 04:53 PM
Gibbs Michael TerrenceGeneral CounselJan 31Sale3.359393,14656,248Feb 05 04:55 PM
McDonough JohnPresident & CEOJan 31Sale3.354,89516,398449,131Feb 05 04:54 PM
Lowery Thomas J.Chief Scientific OfficerJan 31Sale3.352,1667,25671,060Feb 05 04:53 PM